Wells Fargo & Company »

Bridgebio Oncology Therapeut shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut (BBOT) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8k 300 12.52

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom Put Option (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Call Option (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)

View all positions for Wells Fargo & Company

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
EcoR1 Capital
Alphabet
Enavate Sciences GP
Citadel Advisors
Paradigm Biocapital Advisors
BlackRock
Novo A/S
Adage Capital Partners GP
Laurion Capital Management
Eventide Asset Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut